Demonstrates a novel cycloaddition technique in drug discovery, suggesting new avenues for bioactive molecule development.
Heterobicyclo[3.1.1]heptanes (HBCHeps) are highly valuable bioisosteres of heteroaromatics. Herein, we report an iodide-catalyzed formal (3 + 3) cycloaddition of bicyclo[1.1.0]butanes with amides, providing modular access to 2-oxa-4-azabicyclo[3.1.1]hept-3-enes.This practical, metal-free method exhibits broad functional group tolerance and enables late-stage diversification of bioactive molecules, offering a versatile platform for constructing sp3-rich pyridine bioisosteres in drug discovery.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: